{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:42:32Z","timestamp":1777401752553,"version":"3.51.4"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hereditary transthyretin amyloidosis (ATTRv) is an autosomal dominant inherited systematic disease primarily affecting the peripheral and autonomic nervous system, heart, eyes and kidney. Over 140 variants have been identified worldwide, with the Gly103Arg variant reported exclusively in China. This variant is characterized by early onset eye manifestations, making accurate and timely diagnosis difficult. Therefore, we conducted a case study and literature review to investigate the clinical characteristics of the Gly103Arg variant in hereditary transthyretin amyloidosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We identified three patients and an asymptomatic carrier in a four-generation family by sequencing the TTR gene. The proband underwent a lumbar puncture, electromyography, abdominal fat biopsy, among other tests. Case reports of Gly103Arg variant were retrieved through a literature search for an analysis of clinical characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study included clinical data of 44 patients. Our literature review collected data on 41 patients and the present report supplied 3 patients with the Gly103Arg variant. The mean age at onset was 39.1\u2009\u00b1\u20094.27\u2009years (range 30\u201347\u2009years) with a female ratio of 52.3%. All cases were reported in China, predominantly in southern regions, especially Yunan and Guizhou Provinces. The initial manifestation was blurred vision, except for one case presenting with numbness in the upper extremities. All of them had vitreous opacity; 17 cases had peripheral neuropathy,6 cases had autonomic neuropathy, and 3 cases had cardiopathy. No disease-related deaths have been reported to date.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The Gly103Arg variant is unique to the Chinese population, frequently occurring in southern China. The main clinical manifestations are blurred vision, vitreous opacity, and neuropathy, with cardiopathy being rare. ATTRv should be considered if a patient diagnosed with CIDP does not respond to related therapy. Abdominal fat biopsy is a convenient and accurate diagnostic method.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1471131","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T04:28:16Z","timestamp":1725856096000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The Gly103Arg variant in hereditary transthyretin amyloidosis"],"prefix":"10.3389","volume":"15","author":[{"given":"Yihan","family":"Xiong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gongcheng","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaoping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiantang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kexing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoman","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/jnnp-2021-327909","article-title":"Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis","volume":"93","author":"Carroll","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"821003","DOI":"10.3389\/fneur.2021.821003","article-title":"TTR Gly83Arg Mutation: beyond familial vitreous amyloidosis","volume":"12","author":"Li","year":"2022","journal-title":"Front Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"972501","DOI":"10.3389\/fgene.2022.972501","article-title":"Case report: hereditary transthyretin (ATTRv) amyloidosis: the p.G103R mutation of the transthyretin gene in a Han Chinese family is associated with vitreous hemorrhage","volume":"13","author":"Shen","year":"2022","journal-title":"Front Genet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/13506129.2014.892871","article-title":"Chinese familial transthyretin amyloidosis with vitreous involvement is associated with the transthyretin mutation Gly83Arg: a case report and literature review","volume":"21","author":"Yin","year":"2014","journal-title":"Amyloid"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.18240\/ijo.2023.01.19","article-title":"Clinical features of retinal amyloid angiopathy with transthyretin Gly83Arg variant","volume":"16","author":"Gang","year":"2023","journal-title":"Int J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e520","DOI":"10.1111\/aos.13425","article-title":"Familial vitreous amyloidosis resulting from transthyretin variant Gly83Arg","volume":"95","author":"Xie","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"ref7","first-page":"1631","article-title":"G83R in the transthyretin gene is associated with hereditary vitreous amyloidosis in Han Chinese families","volume":"19","author":"Zhang","year":"2013","journal-title":"Mol Vis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/eye.2013.217","article-title":"Ophthalmic manifestations in a Chinese family with familial amyloid polyneuropathy due to a TTR Gly83Arg mutation","volume":"28","author":"Liu","year":"2014","journal-title":"Eye"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.18240\/ijo.2023.07.14","article-title":"Rare manifestation of familial vitreous amyloidosis caused by Gly103Arg transthyretin","volume":"16","author":"Feng","year":"2023","journal-title":"Int J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3980\/j.issn.2222-3959.2011.03.26","article-title":"Transthyretin Arg-83 mutation in vitreous amyloidosis","volume":"4","author":"Chen","year":"2011","journal-title":"Int J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s13023-022-02481-9","article-title":"Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China","volume":"17","author":"He","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s00415-019-09688-0","article-title":"Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy","volume":"268","author":"Adams","year":"2021","journal-title":"J Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ajo.2017.09.001","article-title":"Ocular manifestations of familial transthyretin amyloidosis","volume":"183","author":"Reynolds","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Plant\u00e9-Bordeneuve","year":"2011","journal-title":"Lancet Neurol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1212\/01.wnl.0000178983.20975.af","article-title":"Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis","volume":"65","author":"Nakamura","year":"2005","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1136\/jnnp.72.6.767","article-title":"Anti-GT1a IgG in Guillain-Barre syndrome","volume":"72","author":"Koga","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1212\/WNL.0000000000005777","article-title":"Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy","volume":"91","author":"Lozeron","year":"2018","journal-title":"Neurol Int"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1212\/01.wnl.0000267338.45673.f4","article-title":"Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP)","volume":"69","author":"Plante-Bordeneuve","year":"2007","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13023-020-01565-8","article-title":"Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis","volume":"15","author":"Paulsson Rokke","year":"2020","journal-title":"Orphanet J Rare Dis"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1471131\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T04:28:25Z","timestamp":1725856105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1471131\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":19,"alternative-id":["10.3389\/fneur.2024.1471131"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1471131","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]},"article-number":"1471131"}}